AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

Black Americans have a higher likelihood of having asthma-COPD overlap syndrome (ACOS) but may not know it. Here’s what you ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.